Manipulating the Genome of Human Embryos: Some Unforeseen Effects
By Craig Holdrege,
The Nature Institute
| 06. 22. 2015
Untitled Document
In recent years scientists have developed powerful tools to create specific breaks in DNA sequences. They can then either repair those breaks or introduce new DNA into the sequence at the site of the break. These are called genome editing techniques. Two main techniques at present are the CRISPR-Cas9 system and zinc-finger nucleases. In principle, researchers can modify any part of the genome. They have achieved intended modifications in experiments with human and animal cells and also with mouse embryos. But the specific alterations do not always occur and there are also unintended effects.
The techniques are not as precise as they are sometimes made out to be, so there is every reason for caution in their application, especially in connection with the manipulation of human cells or human embryos. But over and beyond technical issues is the pressing ethical concern: should researchers cross the line into genetically manipulating human embryos?
Knowing that scientists in China were performing these experiments, two groups of researchers and others published comments in Science and Nature in March 2015 warning about...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...